相关实验视频

Updated: Jul 16, 2025

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on: April 22, 2019

SLA2是HNSCC的预后标志物,与瘤微环境中的免疫细胞透相关

Zhongbiao Wu¹, Chengkun You², Zhongyan Zhu³

¹Department of Otolaryngology, Jiangxi Hospital of Integrated Traditional Chinese and Western Medicine, 90 Bayi Avenue, Xihu District, Nanchang, 330003, Jiangxi, China.

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery

|September 9, 2023

概括

类似Src的适应器2基因 (SLA2) 在头部和部状细胞癌 (HNSCC) 中升高,其更高的表达与更好的患者预后有关. SLA2影响瘤微环境中的免疫细胞透,这表明它有可能成为免疫疗法点.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
遗传学是一个遗传学.

背景情况:

头部和部状细胞癌 (HNSCC) 是一个重要的全球健康问题.
了解推动HNSCC进展和免疫逃避的分子机制对于开发有效疗法至关重要.

研究的目的:

为了研究HNSCC.中Src-like适应器2基因 (SLA2) 的表达.
为了评估SLA2在HNSCC患者的预后值.
确定SLA2对瘤微环境 (TME) 中免疫细胞透的影响.

主要方法:

来自TCGA,TIMER和GEPIA的数据集的生物信息学分析.
在HNSCC中,SLA2表达与预后,免疫检查点,TME和免疫细胞透的相关性分析.
基因本体学 (GO) 功能注释和KEGG通路分析,以探索SLA2的致癌机制.

主要成果:

与正常组织相比,HNSCC组织中的SLA2信使核糖核酸 (mRNA) 水平显著增加.
高SLA2表达是一种独立的预后因素,与HNSCC的良好预后有关.
SLA2表达与各种免疫细胞的透具有积极的相关性,包括B细胞,CD8+ T细胞,CD4+ T细胞,巨细胞,中性粒细胞和树突细胞.
与SLA2相关的基因参与了与免疫相关的过程,如白细胞细胞粘附,并通过细胞粘附分子 (CAM) 和化学激素信号传递等途径进行丰富.

结论:

在HNSCC中,SLA2表达是上调调节的,并且与良好的预后有关.
在TME中,SLA2在调节瘤透免疫细胞方面发挥作用.
SLA2 代表了 HNSCC 免疫疗法的潜在治疗标.

关键词:

头部和部状细胞癌 (HNSCC)预测预后预测预测类似Src的适应器2基因 (SLA2)瘤免疫细胞的透.瘤微环境是一个微环境.

更多相关视频

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis

Published on: April 12, 2024

Predictive Immune Modeling of Solid Tumors

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

相关概念视频

lncRNA - Long Non-coding RNAs

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...